G. Kelly Martin Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for G. Kelly Martin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of G. Kelly Martin. G. Kelly Martin is a Director in QUESTCOR PHARMACEUTICALS INC ($QSC) and a CEO and President in Radius Health, Inc. ($RDUS) and an Chief Executive Officer in Novan, Inc. ($NOVN) and a Director in Novan, Inc. ($NOVN) and an Interim Chief ExecutiveOfficer in Novan, Inc. ($NOVN).
Address: 1300 NORTH KELLOGG DRIVE, SUITE D ANAHEIM 92807 CA
Companies in which G. Kelly Martin is an Insider
Novan, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of G. Kelly Martin: Chief Executive Officer, Interim Chief ExecutiveOfficer, Director
Holdings: 45,000 shares
Current Value: $183,150
Latest Transaction: Aug 02 2019
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
QUESTCOR PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of G. Kelly Martin: Director
Holdings: 0 shares
Latest Transaction: Aug 18 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Radius Health, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of G. Kelly Martin: CEO and President
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 23 2021
$RDUS Market Capitalization: $1.86B
$RDUS Previous Close: $41.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of G. Kelly Martin
Sentiment: All, NOVN, QSC, RDUS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | RDUS | Radius Health, Inc ... | Martin G. Kelly | CEO and President | Option Exercise | A | 28.60 | 460,000 | 13,156,000 | 460,000 | |
| Apr 29 2020 | RDUS | Radius Health, Inc ... | Martin G. Kelly | CEO and President | Option Exercise | A | 16.46 | 575,000 | 9,464,500 | 575,000 | |
| Aug 02 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Option Exercise | A | 3.80 | 1,000,000 | 3,800,000 | 1,000,000 | |
| May 30 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.97 | 1,500 | 2,955 | 45,000 | 43.5 K to 45 K (+3.45 %) |
| May 29 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 2.15 | 3,500 | 7,525 | 43,500 | 40 K to 43.5 K (+8.75 %) |
| May 21 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.43 | 40,000 | 57,200 | 40,000 | 0 to 40 K |
| May 21 2019 | NOVN | Novan, Inc. | Martin G. Kelly | Chief Executive Off ... | Buy | P | 1.43 | 40,000 | 57,200 | 40,000 | 0 to 40 K |